HPV16 variants in squamous intraepithelial lesions in human immunodeficiency virus-negative and -positive Brazilian women

Viral Immunology

Volumn 19, Issue 2, 2006, Pages 340-345

  Gheit, Tarik ^a   Simoes, Renata Toscano ^b   Tommasino, Massimo ^a   Donadi, Eduardo Antonio ^b   Gonçalves, Maria Alice Guimarães ^a,b  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BRAZIL; CANCER GRADING; CLINICAL ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; EUROPE; FEMALE; FISHER EXACT TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; IMMUNOCOMPETENCE; SQUAMOUS EPITHELIUM; SQUAMOUS INTRAEPITHELIAL LESION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX DISEASE; UTERINE CERVIX EPITHELIUM; VIRUS INFECTION; VIRUS STRAIN; VIRUS TYPING; WART VIRUS;

ADOLESCENT; ADULT; BRAZIL; CARCINOMA, SQUAMOUS CELL; FEMALE; HIV INFECTIONS; HUMAN PAPILLOMAVIRUS 16; HUMANS; MIDDLE AGED; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; REPRESSOR PROTEINS; UTERINE CERVICAL NEOPLASMS; VARIATION (GENETICS);

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN PAPILLOMAVIRUS;

EID: 33745884708     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2006.19.340     Document Type: Article

References (40)

1. Alvarez-Salas, L.M., and E. Lopez-Bayghen. 1995. [Genetic regulation of human genital papillomaviruses]. Salud Publica Mex. 37:241-247.
2. Bernard, H.U., S.Y. Chan, M.M. Manos, C.K. Ong, L.L. Villa, H. Delius, C.L. Peyton, H.M. Bauer, and C.M. Wheeler. 1994. Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J. Infect. Dis. 170:1077-1085.
3. Berumen, J., R.M. Ordonez, E. Lazcano, J. Salmeron, S.C. Galvan, R.A. Estrada, E. Yunes, A. Garcia-Carranca, G. Gonzalez-Lira, and A. Madrigal-de la Campa. 2001. Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case-control study. J. Natl. Cancer Inst. 93:1325-1330.
4. Bontkes, H.J., M. van Duin, T.D. de Gruijl, M.F. Duggan-Keen, J.M. Walboomers, M.J. Stukart, R.H. Verheijen, T.J. Helmerhorst, C.J. Meijer, R.J. Scheper, F.R. Stevens, P.A. Dyer, P. Sinnott, and P.L. Stern. 1998. HPV 16 infection and progression of cervical intra-epithelial neoplasia: analysis of HLA polymorphism and HPV 16 E6 sequence variants. Int. J. Cancer 78:166-171.
5. Bosch, F.X., M.M. Manos, N. Muñoz, M. Sherman, A.M. Jansen, J. Peto, M.H. Schiffman, V. Moreno, R. Kurman, and K.V. Shah. 1995. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J. Natl. Cancer Inst. 87:796-802.
6. Casas, L., S.C. Galvan, R.M. Ordonez, N. Lopez, M. Guido, and J Berumen. 1999. Asian-american variants of human papillomavirus type 16 have extensive mutations in the E2 gene and are highly amplified in cervical carcinomas. Int. J. Cancer 83:449-455.
7. Chaturvedi, A.K., J.A. Brinkman, A.M. Gaffga, J. Dumestre, R.A. Clark, P.S. Braly, K. Dunlap, P.J. Kissinger, and M.E. Hagensee. 2004. Distribution of human papillomavirus type 16 variants in human immunodeficiency virus type 1-positive and -negative women. J. Gen. Virol. 85:1237-1241.
8. Clifford, G.M., J.S. Smith, T. Aguado, and S. Franceschi. 2003. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br. J. Cancer 89:101-105.
9. Cruz, M.R., D.M. Cerqueira, W.B. Cruz, G.N. Camara, M.M. Brigido, E.G. Silva, L.G. Carvalho, and C.R. Martins. 2004. Prevalence of human papillomavirus type 16 variants in the Federal District, Central Brazil. Mem. Inst. Oswaldo Cruz 99:281-282.
10. Hankins, C., F. Coutlee, N. Lapointe, P. Simard, T. Tran, J. Samson, and L. Hum. 1999. Prevalence of risk factors associated with human papillomavirus infection in women living with HIV. Canadian Women's HIV Study Group. Can Med Assoc J 160:185-191.
11. Higuchi, R. 1989. pp 31-38. Simple and rapid preparation of samples for PCR. Erlich, H.A., ed. PCR technology. Stockton Press: New York.
12. Hildesheim, A., and S.S. Wang. 2002. Host and viral genetics and risk of cervical cancer: a review. Virus Res. 89:229-240.
13. Ho, L., S.Y. Chan, R.D. Burk, B.C. Das, K. Fujinaga, J.P. Icenogle, et al. 1993. The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations. J. Virol. 67:6413-6423.
14. Hu, X., Z. Guo, P. Tianyun, F. Ponten, E. Wilander, S. Andersson, and J. Ponten. 1999. HPV typing and HPV16 E6-sequence variations in synchronous lesions of cervical squamous-cell carcinoma from Swedish patients. Int. J. Cancer 83:34-37.
15. Icenogle, J.P., M. Laga, D. Miller, A.T. Manoka, R.A. Tucker, and W.C. Reeves. 1992. Genotypes and sequence variants of human papillomavirus DNAs from human immunodeficiency virus type 1-infected women with cervical intraepithelial neoplasia. J. Infect. Dis. 166:1210-1216.
16. Jamieson, D.J., A. Duerr, R. Burk, R.S. Klein, P. Paramsothy, P. Schuman, S. Cu-Uvin, and K. Shah. 2002. Characterization of genital human papillomavirus infection in women who have or who are at risk of having HIV infection. Am. J. Obstet. Gynecol. 186:21-27.
17. Lisker, R., E. Ramirez, R.P. Briceno, J. Granados, and V. Babinsky. 1990. Gene frequencies and admixture estimates in four Mexican urban centers. Hum. Biol. 62:791-801.
18. Londesborough, P., L. Ho, G. Terry, J. Cuzick, C. Wheeler, and A. Singer. 1996. Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities. Int. J. Cancer 69:364-368.
19. Lowndes, C.M., F.I. Bastos, K.M. Giffm, A.C. Vaz dos Reis, E. d'Orsi, and M. Alary. 2000. Differential trends in mortality from AIDS in men and women in Brazil (1984-1995). AIDS 14:1269-1273.
20. Mayrand, M.H., F. Coutlee, C. Hankins, N. Lapointe, P. Forest, M. de Ladurantaye, and M. Roger. 2000. Detection of human papillomavirus type 16 DNA in consecutive genital samples does not always represent persistent infection as determined by molecular variant analysis. J. Clin. Microbiol. 38:3388-3393.
21. Nindl, I., K. Rindfleisch, B. Lotz, A. Schneider, and M. Durst. 1999. Uniform distribution of HPV 16 E6 and E7 variants in patients with normal histology, cervical intraepithelial neoplasia and cervical cancer. Int. J. Cancer 82:203-207.
22. Palefsky, J.M., H. Minkoff, L.A. Kalish, A. Levine, H.S. Sacks, P. Garcia, M. Young, S. Melnick, P. Miotti, and R. Burk. 1999. Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. J. Natl. Cancer Inst. 91:226-236.
23. Parkin, D.M., P. Pisani, and J. Ferlay. 1999. Estimates of the worldwide incidence of 25 major cancers in 1990. Int. J. Cancer 80:827-841.
24. Perez-Gallego, L., G. Moreno-Bueno, D. Sarrio, A. Suarez, C. Gamallo, and J. Palacios. 2001. Human papillomavirus-16 E6 variants in cervical squamous intraepithelial lesions from HIV-negative and HIV-positive women. Am. J. Clin. Pathol. 116:143-148.
25. Saiki, R.K., D.H. Gelfand, S. Stoffel, S.J. Scharf, R. Higuchi, G.T. Horn, K.B. Mullis, and H.A. Erlich. 1988. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487-491.
26. Sanguinetti, C.J., N.E. Dias, and A.J. Simpson. 1994. Rapid silver staining and recovery of PCR products separated on polyacrylamide gels. Biotechniques 17:914-921
27. Schlecht, N.F., R.D. Burk, J.M. Palefsky, H. Minkoff, X. Xue, L.S. Massad, M. Bacon, A.M. Levine, K. Anastos, S.J. Gange, D.H. Watts, M.M. Da Costa, Z. Chen, J.Y. Bang, M. Fazzari, C. Hall, and H.D. Strickler. 2005. Variants of human papillomaviruses 16 and 18 and their natural history in human immunodeficiency virus-positive women. J. Gen. Virol. 86:2709-2720.
28. Stewart, A.C., A.M. Eriksson, M.M. Manos, N. Muñoz, F.X. Bosch, J. Peto, and C.M. Wheeler. 1996. Intratype variation in 12 human papillomavirus types: a worldwide perspective. J. Virol. 70:3127-3136.
29. UNAIDS/WHO. 2004. pp 57-61. Latin America. UNAIDS/WHO, ed. AIDS Epidemic Update: December 2004. UNAIDS/WHO: Geneva.
30. Villa, L.L., L. Sichero, P. Rahal, O. Caballero, A. Ferenczy, T. Rohan, and E.L. Franco. 2000. Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. J. Gen. Virol. 81:2959-2968.
31. Walboomers, J.M., M.V. Jacobs, M.M. Manos, F.X. Bosch, J.A. Kummer, K.V. Shah, P.J. Snijders, J. Peto, C.J. Meijer, and N. Muñoz. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189:12-19.
32. Xi, L.F., C.W. Critchlow, C.M. Wheeler, L.A. Koutsky, D.A. Galloway, J. Kuypers, J.P. Hughes, S.E. Hawes, C. Surawicz, G. Goldbaum, K.K. Holmes, and N.B. Kiviat. 1998. Risk of anal carcinoma in situ in relation to human papillomavirus type 16 variants. Cancer Res. 58:3839-3844.
33. Xi, L.F., G.W. Demers, L.A. Koutsky, N.B. Kiviat, J. Kuypers, D.H. Watts, K.K. Holmes, and D.A. Galloway. 1995. Analysis of human papillomavirus type 16 variants indicates establishment of persistent infection. J. Infect. Dis. 172:747-755.
34. Xi, L.F., L.A. Koutsky, D.A. Galloway, J. Kuypers, J.P. Hughes, C.M. Wheeler, K.K. Holmes, and N.B. Kiviat. 1997. Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia. J. Natl. Cancer Inst. 89:796-802.
35. Yamada, T., M.M. Manos, J. Peto, C.E. Greer, N. Muñoz, F.X. Bosch, and C.M. Wheeler. 1997. Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J. Virol. 71:2463-2472.
36. Yang, B.H., F.I. Bray, D.M. Parkin, J.W. Sellors, and Z.F. Zhang. 2004. Cervical cancer as a priority for prevention in different world regions: an evaluation using years of life lost. Int. J. Cancer 109:418-424.
37. Zehbe, I., R. Tachezy, J. Mytilineos, G. Voglino, I. Mikyskova, H. Delius, A. Marongiu, L. Gissmann, E. Wilander, and M. Tommasino. 2001. Human papillomavirus 16 E6 polymorphisms in cervical lesions from different European populations and their correlation with human leukocyte antigen class II haplotypes. Int. J. Cancer 94:711-716.
38. Zehbe, I., G. Voglino, H. Delius, E. Wilander, and M. Tommasino. 1998. Risk of cervical cancer and geographical variations of human papillomavirus 16 E6 polymorphisms. Lancet 352:1441-1442.
39. Zehbe, I., E. Wilander, H. Delius, and M. Tommasino. 1998. Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. Cancer Res. 58:829-833.
40. zur Hausen, H. 1994. Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. Curr. Top. Microbiol. Immunol. 186:131-156.